These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21049553)

  • 1. Prognostic relevance of β-catenin expression in T2-3N0M0 esophageal squamous cell carcinoma.
    Situ DR; Hu Y; Zhu ZH; Wang J; Long H; Rong TH
    World J Gastroenterol; 2010 Nov; 16(41):5195-202. PubMed ID: 21049553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and association of CD44v6 with prognosis in T2-3N0M0 esophageal squamous cell carcinoma.
    Yang H; Liu J; Yu H; Sun P; Hu Y; Zhong J; Zhu Z
    J Thorac Dis; 2014 Feb; 6(2):91-8. PubMed ID: 24605222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
    Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
    Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma.
    Lv J; Cao XF; Ji L; Zhu B; Wang DD; Tao L; Li SQ
    Med Oncol; 2012 Mar; 29(1):151-60. PubMed ID: 21259057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
    Deng F; Zhou K; Cui W; Liu D; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3045-53. PubMed ID: 26045816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma.
    Wang W; Xue L; Wang P
    Med Oncol; 2011 Mar; 28(1):163-9. PubMed ID: 20143187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis.
    Zhao XJ; Li H; Chen H; Liu YX; Zhang LH; Liu SX; Feng QL
    World J Gastroenterol; 2003 Feb; 9(2):225-32. PubMed ID: 12532436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Wnt1/beta-catenin with clinical pathological characteristics and prognosis of esophageal squamous cell carcinoma.
    Lv J; Cao XF; Ji L; Zhu B; Tao L; Wang DD
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):363-9. PubMed ID: 20491588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulated γ-catenin expression is associated with tumor aggressiveness in esophageal cancer.
    Fang WK; Liao LD; Gu W; Chen B; Wu ZY; Wu JY; Shen J; Xu LY; Li EM
    World J Gastroenterol; 2014 May; 20(19):5839-48. PubMed ID: 24914344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
    Zhang Y; Liu YP; Du K; Wang H; Wang XL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
    Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
    Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
    Liu L; Yang Z; Ni W; Xuan Y
    Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
    Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
    Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and significance of tumor drug resistance related proteins and beta-catenin in esophageal squamous cell carcinoma.
    Gan SY; Zhong XY; Xie SM; Li SM; Peng H; Luo F
    Chin J Cancer; 2010 Mar; 29(3):300-5. PubMed ID: 20193114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
    Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2.
    Wang W; Zhu Y; Li S; Chen X; Jiang G; Shen Z; Qiao Y; Wang L; Zheng P; Zhang Y
    Oncotarget; 2016 May; 7(18):25668-82. PubMed ID: 27015363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic HDPR1 is involved in regional lymph node metastasis and tumor development via beta-catenin accumulation in esophageal squamous cell carcinoma.
    Hou J; Li EM; Shen JH; Qing-Zhao ; Wu ZY; Xu XE; Wu JY; Qiao-Huang ; Shen J; Guo MZ; Xu LY
    J Histochem Cytochem; 2011 Jul; 59(7):711-8. PubMed ID: 21525190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma.
    Lei Z; Tian D; Zhang C; Zhao S; Su M
    BMC Cancer; 2016 Jul; 16():410. PubMed ID: 27388201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.